Steven Cohen Bluebird Bio, Inc. Transaction History

Point72 Asset Management, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $759,323 - $2.78 Million	575,245 Added 6283.4%	584,400 $806,000
Q3 2023 Nov 14, 2023	BUY	$3.02 - $4.05 $27,321 - $36,640	9,047 Added 8376.85%	9,155 $27,000
Q2 2023 Aug 14, 2023	SELL	$2.79 - $5.03 $2.47 Million - $4.45 Million	-885,592 Reduced 99.99%	108 $0
Q1 2023 May 15, 2023	SELL	$3.14 - $8.22 $1.01 Million - $2.65 Million	-322,389 Reduced 26.69%	885,700 $2.82 Million
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $6.97 Million - $10.3 Million	1,208,089 New	1,208,089 $8.36 Million

Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $2.4 Million - $4.26 Million	815,300 New	815,300 $3.38 Million
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $6.33 Million - $11.8 Million	-563,400 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $10.2 Million - $12.4 Million	563,400 New	563,400 $18 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $886,500 - $1.4 Million	-15,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $1.56 Million - $2.06 Million	-17,500 Reduced 53.85%	15,000 $2.19 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $2.74 Million - $3.51 Million	27,500 Added 550.0%	32,500 $5.1 Million
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $6.95 Million - $9.92 Million	-65,700 Reduced 92.93%	5,000 $854,000
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $5.74 Million - $9.24 Million	70,700	70,700 $12.6 Million

173

104M

827K

1.23M

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $71M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.